SKLICE

SKLICE

  • 7/23/2012
  • Sanofi Pasteur, Inc.
  • Ivermectin 0.5%; lotion.
  • Topical treatment of head lice infestations in patients ≥6 months old.
COMPLERA

COMPLERA

  • 9/22/2011
  • Gilead Sciences, Inc.
  • Emtricitabine 200mg, ­tenofovir disoproxil fumarate 300mg, rilpivirine 25mg; tabs.
  • HIV-1 infection.
EDURANT

EDURANT

  • 9/1/2011
  • Janssen Therapeutics
  • Rilpivirine 25mg; tablets.
  • HIV-1 infection in antiretroviral treatment-naïve adult patients, in combination with other antiretroviral agents.
INCIVEK

INCIVEK

  • 7/14/2011
  • Vertex Pharmaceuticals
  • Telaprevir 375mg; tablets.
  • Chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin in patients with compensated liver disease, including cirrhosis, who are treatment-naïve or who have previously been treated with interferon-based therapy, including prior null responders, and relapsers. Not for use as monotherapy.
VICTRELIS

VICTRELIS

  • 6/9/2011
  • Merck Co., Inc.
  • Boceprevir 200mg; caps.
  • Chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin (PR) in adult patients with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy. Not for use as monotherapy.
ORAVIG

ORAVIG